According to MarketsandMarkets™, the Oligonucleotide Synthesis Market is projected to reach USD 32.72 billion by 2031 from USD 14.64 billion in 2026, at a CAGR of 17.4% during the forecast period.

Therapeutic oligonucleotides act on different stages of pathological gene expression. Standard schematic of oligonucleotide activities in pathogenesis disease progression. Decoys bind to transcription ...

Getting therapeutic drugs past the blood-brain barrier has long been one of medicine's most difficult challenges, limiting our ability to treat conditions like Alzheimer's disease, Parkinson's disease ...

Oligonucleotide therapeutics, including antisense oligonucleotides and small interfering ribonucleic acid (RNA), have emerged as powerful tools for regulating gene expression and treating neurological ...

Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. Scientists have developed a new ...

- The next frontier in oligonucleotide synthesis is the direct synthesis of gene-length sequences. - Ansa synthesized a 1005 base long oligonucleotide with industry-leading accuracy. - Ansa will be ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. This jar was part of the National ...

Peptides and oligonucleotides, often grouped together as TIDES, are increasingly seen as powerful therapeutic tools. 2 Their high specificity, tunable biological activity, and ability to modulate ...